Pubblicazioni

• Is the pathology of posterior cortical atrophy clinically predictable?
• Immunomodulatory effects of ocrelizumab and candidate biomarkers for monitoring treatment response in multiple sclerosis
• Systematic Review on the Role of Lobar Cerebral Microbleeds in Cognition
• Understanding and managing the impact of the Covid-19 pandemic and lockdown on patients with multiple sclerosis
• Apparently isolated CNS involvement in Erdheim-Chester disease: Case report
• Exploring Circulating Long Non-Coding RNAs in Mild Cognitive Impairment Patients' Blood
• Plasma Small Extracellular Vesicles with Complement Alterations in GRN/ C9orf72 and Sporadic Frontotemporal Lobar Degeneration
• Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence
• Plasma Small Extracellular Vesicle Cathepsin D Dysregulation in GRN/C9orf72 and Sporadic Frontotemporal Lobar Degeneration
• Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study
• Singular cases of Alzheimer's disease disclose new and old genetic "acquaintances"
• MicroRNA Expression Signature in Mild Cognitive Impairment Due to Alzheimer's Disease
• The Rise of the GRN C157KfsX97 Mutation in Southern Italy: Going Back to the Fall of the Western Roman Empire
• "Borderline" idiopathic CD4+ T-cell lymphocytopenia presenting with atypical progressive multifocal leukoencephalopathy
• Role of Ocrelizumab in modulating gene and microRNA expression in multiple sclerosis
• Diagnostic contribution of magnetic resonance imaging in an atypical presentation of motor neuron disease
• A cluster of progranulin C157KfsX97 mutations in Southern Italy: clinical characterization and genetic correlations
• Case Report: Histopathology and Prion Protein Molecular Properties in Inherited Prion Disease With a De Novo Seven-Octapeptide Repeat Insertion
• Non-alcoholic acute Wernicke's encephalopathy: role of MRI in non typical cases